Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthstream (HSTM) EBIT (2016 - 2026)

Healthstream has reported EBIT over the past 16 years, most recently at $2.4 million for Q4 2025.

  • Quarterly EBIT rose 121.07% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.2 million through Dec 2025, up 290.03% year-over-year, with the annual reading at $20.2 million for FY2025, 290.13% up from the prior year.
  • EBIT was $2.4 million for Q4 2025 at Healthstream, down from $7.6 million in the prior quarter.
  • Over five years, EBIT peaked at $7.6 million in Q3 2025 and troughed at -$11.4 million in Q4 2024.
  • The 5-year median for EBIT is $3.4 million (2021), against an average of $2.0 million.
  • Year-over-year, EBIT tumbled 1225.65% in 2022 and then surged 121.07% in 2025.
  • A 5-year view of EBIT shows it stood at -$460000.0 in 2021, then tumbled by 1225.65% to -$6.1 million in 2022, then fell by 29.19% to -$7.9 million in 2023, then plummeted by 44.85% to -$11.4 million in 2024, then surged by 121.07% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EBIT are $2.4 million (Q4 2025), $7.6 million (Q3 2025), and $5.9 million (Q2 2025).